| JVMCX | LYRIX | JVMCX / LYRIX | |
| Total Expense Ratio | 1.85 | 0.99 | 187% |
| Annual Report Gross Expense Ratio | 1.86 | 1.00 | 186% |
| Fund Existence | 14 years | 13 years | - |
| Gain YTD | 2.767 | 13.871 | 20% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 100000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 23.9B | 1.16B | 2,067% |
| Annual Yield % from dividends | 0.00 | 0.18 | - |
| Returns for 1 year | 1.52 | 11.94 | 13% |
| Returns for 3 years | 12.13 | 64.75 | 19% |
| Returns for 5 years | 17.72 | 69.74 | 25% |
| Returns for 10 years | 36.94 | 104.11 | 35% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EDD | 5.55 | 0.02 | +0.36% |
| Morgan Stanley Emerging Markets Domestic Debt Fund | |||
| ADBG | 10.45 | 0.02 | +0.19% |
| Leverage Shares 2X Long ADBE Daily ETF | |||
| IBDQ | 25.12 | N/A | N/A |
| iShares iBonds Dec 2025 Term Corporate ETF | |||
| ISHP | 39.07 | N/A | N/A |
| First Trust S-Network Glb E-Com ETF | |||
| NXC | 13.22 | -0.03 | -0.23% |
| Nuveen CA SEL Tax-Free | |||